Neuren Pharmaceuticals | NEU - Net Income

Stock Price
13.00
Daily Change
0.70 5.69%
Monthly
11.30%
Yearly
49.08%
Q2 Forecast
11.77

Neuren Pharmaceuticals reported AUD15.4M in Net Income for its fiscal semester ending in December of 2025.





Net Income Change Date
Akebia Therapeutics USD -12.24M 12.78M Dec/2025
Alaunos Therapeutics USD -1.16M 108K Sep/2025
Avita Medical AUD -11.62M 1.7M Dec/2025
Clinuvel Pharmaceuticals AUD 10.44M 11.65M Dec/2025
Dianthus Therapeutics USD -64.43M 27.67M Dec/2025
Genetic Signatures AUD -6.36M 1.46M Dec/2025
Ionis Pharmaceuticals USD -229M 100.39M Dec/2025
Medical Developments International AUD -226K 121K Dec/2025
Neuren Pharmaceuticals AUD 15.4M 7.88M Dec/2025
Organon & Co USD 160M 15M Sep/2025
Paradigm Biopharmaceuticals AUD -23.24M 16.82M Dec/2025
PYC Therapeutics AUD -22.83M 10.46M Dec/2025
Starpharma Holdings AUD 1.37M 3.67M Dec/2025
Tectonic Therapeutic USD -19.23M 186K Dec/2025
Telix Pharmaceuticals AUD -4.83M 2.54M Dec/2025
Viatris USD -340.1M 211.9M Dec/2025
Xeris Pharmaceuticals USD 11.08M 10.46M Dec/2025